Class I
Ongoing
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical…
Why: Presence of Particulate matter: Particulate matter identified as glass.
- Company
- SUN PHARMACEUTICAL INDUSTRIES INC
Princeton, NJ, United States - Reported
- Jun 17, 2026
- Recall started
- May 12, 2026
- Where sold
- U.S. Nationwide
- Amount
- 675 vials
- Full product description
- DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol, Gujarat, India, NDC 72603-200-01.
- Lots / codes affected
- Lot HAG2581B, expires: 05/31/2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.